Advancing the Development of Pediatric Devices
NCC-PDI brings together teams with excellence and expertise in delivering business, regulatory, legal, scientific, engineering, and clinical services for children.
Expert advice, support services, and fund management for pediatric device innovators.
A pipeline of high-potential pediatric devices for all pediatric subpopulations.
In September 2013, the Sheik Zayed Institute for Pediatric Surgical Innovation (SZI) at the Children’s National Health System and the University of Maryland A. James Clark School of Engineering received a U.S. Food and Drug Administration (FDA) P50 grant to form the National Capital Consortium for Pediatric Device Innovation (NCC-PDI).
In the News
Kolaleh Eskandanian, PhD, is the vice president and chief innovation officer of Children's National Health System in Washington, D.C.
Here, Dr. Eskandanian outlines the big cybersecurity challenges and how she expects her role as the chief innovation officer at Children's National to evolve over the next few years.
While medical device innovation is quite active—at the university level, within incubators, and even in the R&D labs of established firms—there is a substantial lack of products being developed for younger patients. Since pediatric devices have a limited patient base due to most children being relatively healthy (of course, a positive factor), it’s not a focus for a great number of companies as it does not offer the promise of a substantial financial return.
While FY2017's approvals notably served all four pediatric age groups, the majority of pediatric devices approved over the last decade are not indicated for children under the age of 12. What's more, a large portion of the devices indicated for FDA's 'adolescents' category are only authorized for use in patients 18 or older.
WASHINGTON, Sept. 4, 2019 /PRNewswire/ -- Organizers of the $150K "Make Your Medical Device Pitch for Kids!" competition today announced the 12 finalists who are advancing to the live pitch component of the competition scheduled for Sept. 22 during the 7th Annual Pediatric Device Innovation Symposium hosted by Children's National Health System. The pitch competition, sponsored by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI), focuses on Neonatal Intensive Care Unit (NICU) innovations, a pediatric subspecialty that the Food and Drug Administration (FDA) identifies as having a significant unmet need for medical devices.
One of five FDA-funded grant programs focused on addressing these unmet needs, NCC-PDI is led by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System and the A. James Clark School of Engineering at the University of Maryland. Last year, NCC-PDI added new accelerators BioHealth Innovation and MedTech Innovator and design firm partner, Archimedic.
"All of the companies that entered the competition are remarkable, but these finalists impressed us the most because of how their innovative medical devices solve a clinical challenge in the NICU and the feasibility of accelerating their commercialization process," says Kolaleh Eskandanian, Ph.D., MBA, PMP, vice president and chief innovation officer at Children's National and principal investigator of NCC-PDI. "One in 10 babies is born prematurely, making NICU innovation an area where we can positively impact outcomes for a significant number of patients, so we want to support developers with funding, mentorship and regulatory guidance."
The competition is one of many highlights that attendees can expect at the 7th Annual Pediatric Device Innovation Symposium, which co-locates with The MedTech Conference in Boston. The one-day, information-packed gathering of stakeholders from industry, government, academia and patient groups will begin with an opening keynote address from Melinda Richter, Global Head of Johnson & Johnson Innovation – JLABS, a network of life science incubators designed to foster new ideas to transform healthcare for all, including the very youngest of patients.